Jun 15, 2020
Global Market for CRISPR Technology by End User, Application, Region and Key Company Profiles
Jun 10, 2020
Genome Engineering Market to Clock CAGR of 10.9% from 2019 to 2027; CRISPR Gene Edition Tools Present Sizable Revenue Streams, TMR
Jun 03, 2020
Evogene to Participate in CRISPR-IL Consortium to Provide End-to-End Artificial Intelligence System for Genome-Editing
Jun 01, 2020
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
May 11, 2020
MilliporeSigma Granted U.S. Patents for Foundational CRISPR-Cas9 Technology
May 07, 2020
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
Mar 09, 2020
UMD Researcher Establishes a New Viable CRISPR-Cas12b System for Plant Genome Engineering
Jan 23, 2020
Delaware, CRISPR and Cellicon Valley: A Special Event on February 6th
Jan 08, 2020
Locus Biosciences initiates world's first controlled clinical trial for a CRISPR enhanced bacteriophage therapy
Jan 07, 2020
The Global Cancer Tumor Organoids Market, 2025: A $400+ Million Opportunity Assessment
Jan 07, 2020
genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models
Dec 19, 2019
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
Dec 10, 2019
Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform
Nov 26, 2019
Japan and Singapore Grant CRISPR Patents to MilliporeSigma
Nov 12, 2019
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
Oct 22, 2019
Genome Editing/Genome Engineering Market Key Players, Types, Growth, Trends, Competitive Landscape and Forecasts to 2024 - ReportsnReports
Oct 21, 2019
CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics
Oct 01, 2019
University of California expands U.S. CRISPR-Cas9 patent portfolio with issuance of new patent
Sep 30, 2019
Gene-edited, stem cell reporter line could boost cardiac research
Sep 24, 2019
Locus Biosciences selected by FierceBiotech as one of its "Fierce 15" Biotech Companies of 2019